An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Clinical trial NCT02544750 · COMPLETED
Trial details
- NCT number
- NCT02544750
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-31
- Primary completion
- 2021-06-11
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.